Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.7B | 1.5B | 1.5B | 1.6B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | -11M | 64M | 49M | 19M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 34M | 58M | 37M | -36M |
Tax provision | -17M | -46M | -142M | -57M |
Net income | -17M | 12M | 179M | 59M |
Basic EPS | -0.2 | 0.2 | 2.5 | 0.8 |
Diluted EPS | -0.2 | 0.2 | 2.4 | 0.8 |
Basic average shares | 72.3M | 72.3M | 72.3M | 72.3M |
Diluted average shares | 72.8M | 72.8M | 72.8M | 72.8M |
EBITDA | 86M | 116M | 99M | 74M |
Net income from continuing op. | -11M | 64M | 49M | 44M |
Minority interests | -1M | 0 | 0 | -2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |